Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out.
MetadataShow full item record
JournalArchivos de Bronconeumología
AbstractDespite wide antiretroviral scale-up during the past two decades resulting in declining new infections and mortality globally, HIV-associated tuberculosis remains as a major public health concern. Tuberculosis is the leading HIV-associated opportunistic infection and the main cause of death globally and, particularly, in resource-limited settings. Several challenges exist regarding diagnosis, global implementation of latent tuberculosis treatment, management of active tuberculosis, delivery of optimal patient-centered TB and HIV prevention and care in high burden countries. In this article we review the advances on pathogenesis, diagnosis, and treatment after nearly two decades of global roll-out of antiretroviral therapy and discuss the current challenges for the global control of tuberculosis-HIV co-infection.
- Authors: Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P, Holmes KK, Bertozzi S, Bloom BR, Jha P
- Issue date: 2017 Nov 3
- Tuberculosis and HIV co-infection: screening and treatment strategies.
- Authors: Venkatesh KK, Swaminathan S, Andrews JR, Mayer KH
- Issue date: 2011 Jun 18
- Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.
- Authors: Havlir DV, Getahun H, Sanne I, Nunn P
- Issue date: 2008 Jul 23
- [Development of antituberculous drugs: current status and future prospects].
- Authors: Tomioka H, Namba K
- Issue date: 2006 Dec
- Tuberculosis control in people living with HIV/AIDS.
- Authors: Magnabosco GT, Lopes LM, Andrade RL, Brunello ME, Monroe AA, Villa TC
- Issue date: 2016 Sep 9